ABIN966222
antibody from antibodies-online
Targeting: GREM1
CKTSF1B1, CRAC1, DAND2, DRM, gremlin, HMPS
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN966222 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Gremlin 1 (GREM1) (C-Term) antibody
- Antibody type
- Polyclonal
- Antigen
- A synthetic peptide corresponding to a sequence at the C-terminal of human Gremlin 1, identical to the related rat and mouse sequences.< br/>Immunogen was affinity purified.
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- C-Term
- Isotype
- IgG
- Vial size
- 100 μg
- Storage
- At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquotted and stored frozen at -20°C for a longer time.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor.
The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein.
Office-based testing for fecal occult blood: do only in case of emergency.
Skeletal overexpression of gremlin impairs bone formation and causes osteopenia.
Stabile H, Mitola S, Moroni E, Belleri M, Nicoli S, Coltrini D, Peri F, Pessi A, Orsatti L, Talamo F, Castronovo V, Waltregny D, Cotelli F, Ribatti D, Presta M
Blood 2007 Mar 1;109(5):1834-40
Blood 2007 Mar 1;109(5):1834-40
The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein.
Namkoong H, Shin SM, Kim HK, Ha SA, Cho GW, Hur SY, Kim TE, Kim JW
BMC cancer 2006 Mar 18;6:74
BMC cancer 2006 Mar 18;6:74
Office-based testing for fecal occult blood: do only in case of emergency.
Sox HC
Annals of internal medicine 2005 Jan 18;142(2):146-8
Annals of internal medicine 2005 Jan 18;142(2):146-8
Skeletal overexpression of gremlin impairs bone formation and causes osteopenia.
Gazzerro E, Pereira RC, Jorgetti V, Olson S, Economides AN, Canalis E
Endocrinology 2005 Feb;146(2):655-65
Endocrinology 2005 Feb;146(2):655-65
No comments: Submit comment
No validations: Submit validation data